ADD/ADHD Online Information

USA Research Project

Research study to evaluate the effects of Guanfacine (INTUNIV)

The Mount Sinai School of Medicine is conducting a research study to evaluate the effects of Guanfacine (INTUNIV), a medication used in treatment of Attention Deficit Hyperactivity Disorder (ADHD) on brain activation. All participants receive, at no cost: a comprehensive physical exam, a comprehensive psychiatric interview, abbreviated psychological assessment, abbreviated cognitive testing, pre and post treatment fMRI scanning, weekly visits with our study physicians, referral back to primary clinician with progress report of participation, after being stabilized on the medication that works best for the child. Criteria for participation are: confirmed or suspected diagnosis of ADHD, ages 8-15 years, have no metal placed permanently in the body, able to enter and lie still in a scanner for about 1 hour while playing a videogame, and be healthy enough to participate in medication treatment with guanfacine. Contact Beth Krone at 212-659-8833, beth.krone@mssm.edu or P.I. Jeffrey Newcorn at Jeffrey.newcorn@mssm.edu. GCO 09-1825, IRB approved 11/3/11 to 11/2/12.

[Back To Research Menu]

---

Home  About Us  ADD/ADHD News  ADDerwards  Advertising  Books  Contact Us  Creative ADDers  Donate

 Events  Forums  Information  Links  Natural Remedies  ADDers.org News  Research  Resources  Search adders.org

 Site Map  Social Stories  Sponsor Events  Student/Researchers  Support Groups  Supporters



Join us on.... Twitter Facebook

Home